Referencias
1. Hypponen E, Laara E, Reunanen A, Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001 Nov 3;358(9292):1500-3.
2. Billaudel B, Barakat L, Faure-Dussert A. Vitamin D3 deficiency and alterations of glucose metabolism in rat endocrine pancreas. Diabetes Metab 1998;24:344-50.
3. Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J.Endocrinol. 1999;160:87-95.
4. Ortlepp JR, Lauscher J, Hoffmann R, The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med. 2001 Oct;18(10):842-5.
5 Segall JJ. Latitude and ischaemic heart disease [letter]. Lancet 1989;1:1146.
6 Williams FL, Lloyd OL. Latitude and heart disease [letter]. Lancet 1989;1:1072-3.
7. Panda DK, Miao D, Tremblay ML, Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7498-503.
8. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. J.Am.Coll.Nutr. 2000;19:220-7.
9. Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res.Mol.Brain Res. 1996;36:193-6.
10. : Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999;3(1):5-7.
11. Gloth FM, III, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J.Nutr.Health Aging 1999;3:5-7.
12 : Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000 Nov;59(4):531-5.
13. McMichael AJ, Hall AJ. Multiple sclerosis and ultraviolet radiation: time to shed more light.Neuroepidemiology. 2001 Aug;20(3):165-7.
14. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 2001 Dec;15(14):2579-85.
16. Long KZ, Santos JI. Vitamins and the regulation of the immune response. Pediatr.Infect.Dis.J. 1999;18:283-90.
17. Ghezzi A, Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci 2001 Nov;22 Suppl 2:S117-22
18 Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc.Soc.Exp.Biol.Med. 2000;223:230-3
19 Shi H, Norman AW, Okamura WH, Sen A, Zemel MB.1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J. 2001 Dec;15(14):2751-3
20 Speer G, Cseh K, Winkler G, Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol. 2001 Apr;144(4):385-9.
21 Henendez C, Lage M, Peino R, Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue.J Endocrinol. 2001 Aug;170(2):425-31
22 Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? [published erratum appears in Br J Nutr 1998 Dec;80(6):585]. Br.J.Nutr. 1998;79:315-27.
23 Grant WB An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates.Cancer 2002 Jan 1;94(1):272-81
24 Polek TC, Weigel NL. Vitamin D and prostate cancer. J Androl. 2002 Jan-Feb;23(1):9-17.
25 Luscombe CJ, French ME, Liu S, Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes.Br J Cancer. 2001 Nov;85(10):1504-9.
26 Hansen CM, Binderup L, Hamberg KJ, Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci. 2001 Jul 1;6:D820-48.
27 Tuohimaa P, Lyakhovich A, Aksenov N, Vitamin D and prostate cancer. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):125-34
28 Mokady E, Schwartz B, Shany S, A protective role of dietary vitamin D3 in rat colon carcinogenesis. Nutr Cancer. 2000;38(1):65-73.
29 Platz EA, Hankinson SE, Hollis BW, Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1059-65.
30 Tangpricha V, Flanagan JN, Whitlatch LW, 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001 May 26;357(9269):1673-4.
31 Lamprecht SA, Lipkin M. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci. 2001 Dec;952:73-87.
32 Majewski S, Kutner A, Jablonska S. Vitamin D analogs in cutaneous malignancies.Curr Pharm Des. 2000 May;6(7):829-38.
33 Braun MM, Tucker MA. A role for photoproducts of vitamin D in the etiology of cutaneous melanoma? Med Hypotheses. 1997 Apr;48(4):351-4.
34 McAlindon TE, Felson DT, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med 1996; 125: 353-359
35 Lane NE, Nevitt MC, Gore LR, Cummings SR. Serum levels of vitamin D and hip osteoarthritis in elderly women: a longitudinal study. Arthritis Rheum 1997; 40(suppl): S238.
36. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000 Sep;72(3):690-3)
Articulo cedido por...
